ReP USP - Resultado da busca

Artigo de periodico
Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid (2024)
Zahm, Shelia ; Bonde, Jens Peter ; Chiu, Weihsueh A ; Hoppin, Jane ; Kanno, Jun ; Abdallah, Mohamed; Blystone, Chad R ; Calkins, Miriam M ; Dong, Guang Hui ; Dorman, David C; Fry, Rebecca; Guo, Huan; Haug, Line Småstuen ; Hofmann, Jonathan N. ; Iwasaki, Motoki; Machala, Miroslav ; Mancini, Francesca Romana ; Maria-Engler, Silvya Stuchi ; Møller, Peter Rsak ; Ng, Jack Chakmeng; Pallardy, Marc ; Post, Gloria B ; Salihovic, Samira ; Schlezinger, Jennifer ; Soshilov, Anatoly; Steenland, Kyle ; Steffensen, Inger Lise ; Tryndyak, Volodymyr ; White, Alexandra; Woskie, Susan
Source: The Lancet Oncology. Unidade: FCF
Subjects: CARCINOGÊNESE, PRODUTOS QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAHM, Shelia et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, v. 25, n. 1, p. 16-17, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/S1470-2045(23)00622-8. Acesso em: 03 nov. 2025.
APA
Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, 25( 1), 16-17. doi:10.1016/S1470-2045(23)00622-8
NLM
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2025 nov. 03 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8
Vancouver
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2025 nov. 03 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8
Artigo de periodico
Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis (2020)
Conti, Aline de ; Tryndyak, Volodymyr ; Heidor, Renato ; Jimenez, Leandro; Moreno, Fernando Salvador ; Beland, Frederick A ; Rusyn, Ivan; Pogribny, Igor P
Source: Journal of Nutritional Biochemistry. Unidade: FCF
Subjects: LIPÍDEOS, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTI, Aline de et al. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis. Journal of Nutritional Biochemistry, v. 86, p. 1-9 art. 108496, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jnutbio.2020.108496. Acesso em: 03 nov. 2025.
APA
Conti, A. de, Tryndyak, V., Heidor, R., Jimenez, L., Moreno, F. S., Beland, F. A., et al. (2020). Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis. Journal of Nutritional Biochemistry, 86, 1-9 art. 108496. doi:10.1016/j.jnutbio.2020.108496
NLM
Conti A de, Tryndyak V, Heidor R, Jimenez L, Moreno FS, Beland FA, Rusyn I, Pogribny IP. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis [Internet]. Journal of Nutritional Biochemistry. 2020 ; 86 1-9 art. 108496.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.jnutbio.2020.108496
Vancouver
Conti A de, Tryndyak V, Heidor R, Jimenez L, Moreno FS, Beland FA, Rusyn I, Pogribny IP. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis [Internet]. Journal of Nutritional Biochemistry. 2020 ; 86 1-9 art. 108496.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/j.jnutbio.2020.108496
Artigo de periodico
MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis (2017)
Conti, Aline de; Ortega, Juliana Festa; Tryndyak, Volodymyr; Dreval, Kostiantyn; Moreno, Fernando Salvador ; Rusyn, Ivan; Beland, Frederick A; Pogribny, Igor P
Source: Oncotarget. Unidade: FCF
Subjects: CARCINOGÊNESE, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTI, Aline de et al. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis. Oncotarget, v. 8, n. 51, p. 88517-88528, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.19774. Acesso em: 03 nov. 2025.
APA
Conti, A. de, Ortega, J. F., Tryndyak, V., Dreval, K., Moreno, F. S., Rusyn, I., et al. (2017). MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis. Oncotarget, 8( 51), 88517-88528. doi:10.18632/oncotarget.19774
NLM
Conti A de, Ortega JF, Tryndyak V, Dreval K, Moreno FS, Rusyn I, Beland FA, Pogribny IP. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis [Internet]. Oncotarget. 2017 ; 8( 51): 88517-88528.[citado 2025 nov. 03 ] Available from: https://doi.org/10.18632/oncotarget.19774
Vancouver
Conti A de, Ortega JF, Tryndyak V, Dreval K, Moreno FS, Rusyn I, Beland FA, Pogribny IP. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis [Internet]. Oncotarget. 2017 ; 8( 51): 88517-88528.[citado 2025 nov. 03 ] Available from: https://doi.org/10.18632/oncotarget.19774
Artigo de periodico
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein (2016)
Ortega, Juliana Festa; Conti, Aline de; Tryndyak, Volodymyr; Furtado, kelly Silva; Heidor, Renato ; Horst, Maria Aderuza; Fernandes, Laura Helena Gasparini; Tavares, Paulo Eduardo Latorre Martins; Pogribna, Marta; Shpyleva, Svitlana; Beland, Frederick A; Pogribny, Igor P; Moreno, Fernando Salvador
Source: Oncotarget. Unidade: FCF
Subjects: HEPATOPATIAS, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORTEGA, Juliana Festa et al. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget, v. 7, n. 17, p. 24339-24347, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.8248. Acesso em: 03 nov. 2025.
APA
Ortega, J. F., Conti, A. de, Tryndyak, V., Furtado, kelly S., Heidor, R., Horst, M. A., et al. (2016). Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget, 7( 17), 24339-24347. doi:10.18632/oncotarget.8248
NLM
Ortega JF, Conti A de, Tryndyak V, Furtado kelly S, Heidor R, Horst MA, Fernandes LHG, Tavares PELM, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein [Internet]. Oncotarget. 2016 ; 7( 17): 24339-24347.[citado 2025 nov. 03 ] Available from: https://doi.org/10.18632/oncotarget.8248
Vancouver
Ortega JF, Conti A de, Tryndyak V, Furtado kelly S, Heidor R, Horst MA, Fernandes LHG, Tavares PELM, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein [Internet]. Oncotarget. 2016 ; 7( 17): 24339-24347.[citado 2025 nov. 03 ] Available from: https://doi.org/10.18632/oncotarget.8248
Artigo de periodico
Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis (2014)
Guariento, Aline H; Furtado, kelly Silva; Conti, Aline de; Campos, Adriana; Purgatto, Eduardo ; Carrilho, Jessica; Guerra-Shinohara, Elvira Maria ; Tryndyak, Volodymyr; Han, Tao; Fuscoe, James C; Ross, Sharon Ann; Beland, Frederick A; Pogribny, Igor P; Moreno, Fernando Salvador
Source: International Journal of Cancer. Unidade: FCF
Subjects: CARCINOGÊNESE ANIMAL, ÁCIDO FÓLICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUARIENTO, Aline H et al. Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis. International Journal of Cancer, v. 135, n. 1, p. 7-18, 2014Tradução . . Disponível em: https://doi.org/10.1002/ijc.28642. Acesso em: 03 nov. 2025.
APA
Guariento, A. H., Furtado, kelly S., Conti, A. de, Campos, A., Purgatto, E., Carrilho, J., et al. (2014). Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis. International Journal of Cancer, 135( 1), 7-18. doi:10.1002/ijc.28642
NLM
Guariento AH, Furtado kelly S, Conti A de, Campos A, Purgatto E, Carrilho J, Guerra-Shinohara EM, Tryndyak V, Han T, Fuscoe JC, Ross SA, Beland FA, Pogribny IP, Moreno FS. Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis [Internet]. International Journal of Cancer. 2014 ; 135( 1): 7-18.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/ijc.28642
Vancouver
Guariento AH, Furtado kelly S, Conti A de, Campos A, Purgatto E, Carrilho J, Guerra-Shinohara EM, Tryndyak V, Han T, Fuscoe JC, Ross SA, Beland FA, Pogribny IP, Moreno FS. Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis [Internet]. International Journal of Cancer. 2014 ; 135( 1): 7-18.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1002/ijc.28642
Artigo de periodico
The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway (2013)
De Conti, Aline; Tryndyak, Volodymyr; Koturbash, Igor; Heidor, Renato ; Kuroiwa-Trzmielina, Joice; Ong, Thomas Prates ; Beland, Frederick A; Moreno, Fernando Salvador ; Pogribny, Igor P
Source: Carcinogenesis. Unidade: FCF
Subjects: CARCINOGÊNESE ANIMAL, NEOPLASIAS (QUIMIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE CONTI, Aline et al. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis, v. 34, n. 8, p. 1900-1906, 2013Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgt124. Acesso em: 03 nov. 2025.
APA
De Conti, A., Tryndyak, V., Koturbash, I., Heidor, R., Kuroiwa-Trzmielina, J., Ong, T. P., et al. (2013). The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis, 34( 8), 1900-1906. doi:10.1093/carcin/bgt124
NLM
De Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway [Internet]. Carcinogenesis. 2013 ; 34( 8): 1900-1906.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1093/carcin/bgt124
Vancouver
De Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway [Internet]. Carcinogenesis. 2013 ; 34( 8): 1900-1906.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1093/carcin/bgt124

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Non normalized affiliation

Countries of institutions of collaboration